91% interventi oncologici A in tempi previsti in primi 2 mesi’25
Risultati per: Gestione della stenosi mitralica reumatica (MVA <= 1,5 cm)
Questo è quello che abbiamo trovato per te
Protocol of the follow-up of patients with transthyretin amyloid cardiomyopathy by multimodality imaging (FAITH) study: a prospective observational study in patients with ATTR-CM undergoing treatment with tafamidis
Introduction
This prospective observational study of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) undergoing treatment with tafamidis aims at identifying quantitative image markers and comparing imaging modalities regarding the follow-up and prognostication of these patients, with the goal of providing a multiparametric score to predict treatment response.
Methods and analysis
Patients with a board-approved decision to receive tafamidis will undergo, in addition to standard of care, baseline and follow-up cardiovascular magnetic resonance (CMR) scans at 9 and 18 months. In total, the study plans to recruit and scan 60 patients. A blinded read will take place in a CMR research core laboratory. The final statistical analysis will be based on developing a multiparametric score for the prediction of treatment response. The study will be managed through the Amyloidosis Center Charité Berlin, a clinical unit formed from the three clinical campus sites of the Charité in Berlin, using the Berlin Research Network for CMR.
Ethics and dissemination
The study was approved by the Charité—Universitätsmedizin Berlin ethics committee EA1/262/23. The results of the study will be disseminated through international peer-reviewed publications and congress presentations.
Trial registration number
Approved WHO primary register: German Clinical Trials Register: https://www.drks.de/DRKS00033884. WHO International Clinical Registry Platform: https://trialsearch.who.int/?TrialID=DRKS00033884. Recruitment started on 1 July 2024.
Diagnosi e gestione delle condizioni premaligne gastriche
Linee guida aggiornate per la gestione della malattia renale cronica
Linee guida per la gestione dei pazienti con sindromi coronariche acute
[Articles] Development and validation of an ultrasound-based interpretable machine learning model for the classification of ≤3 cm hepatocellular carcinoma: a multicentre retrospective diagnostic study
A diagnostic model for sHCC was developed and validated using ML and grayscale US from large cohorts. This model significantly improved the diagnostic performance of grayscale US for sHCC compared with experts.
Stenosi valvolare aortica, in Piemonte oltre 4mila casi
Il 18 febbraio a Torino un congresso con i massimi esperti
Gestione farmacologica degli adulti con dislipidemia: linee guida
Linee guida per la prevenzione e la gestione della riattivazione del virus dell’epatite B
Linea guida sulla gestione del sovrappeso e dell’obesità
Linee guida sulla diagnosi e gestione dell’Alzheimer e disturbi collegati
Ridisegnare la gestione delle malattie croniche a partire dal rischio obesità
La disfunzionalità dell’adipe si riflette sui tessuti arteriosi, cardiaci e renali e queste interconnessioni rappresentano una sfida importante per il Ssn, ma anche un’opportunità per migliorare la presa in cura dei pazienti con patologie complesse
Riccardi, ok Cal a Linee guida gestione Sistema sanitario 2025
Rinviato a metà gennaio voto su piano revisione Rete oncologica
Linee guida sulla diagnosi e gestione della MRGE
Evoluzioni per la gestione del tumore del pancreas
Domani ad Ancona congresso scientifico alla Politecnica Marche